The U.S. Securities and Exchange Commission said on Monday that it had settled charges with Becton Dickinson and Co. (BD) ...

Becton, Dickinson settles with SEC for $175M over misleading investors on software flaws in Alaris pumps. Read more here.

Becton, Dickinson and Co. (BDX) or BD, a New Jersey-based medical device manufacturer, has agreed to pay $175 million to the U.S.

The SEC reached a settlement with Becton Dickinson over allegations of misleading investors regarding risks tied to its Alaris infusion pump. The company agreed to a $175 million civil penalty without ...

The SEC has announced a $175 million settlement with Becton Dickinson for misleading investors about risks tied to its Alaris infusion pump. The charges involve the company's failure to disclose ...

Becton, Dickinson & Co. has agreed to a $175 million fine over Securities and Exchange Commission claims it repeatedly misled ...

As per the allegations against the company, Becton did not disclose that its Alaris infusion pumps had various product ...

While Alaris has returned, its long absence could still result in material share erosion in the infusion pump space. The company's executives have historically been the best in the industry in ...

One product of the BD unit are infusion pumps and syringes for IV drips in hospitals. A company spokesperson said that in ...